Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: Necessity of immunosuppressive treatment for sustained improvement

Neurological Research

Volumn 31, Issue 3, 2009, Pages 220-227

  Toriumi, Hayato ^a   Yoshikawa, Masahide ^a   Matsuda, Ryosuke ^a   Nishimura, Fumihiko ^a   Yamada, Shu Ichi ^a   Hirabayashi, Hidehiro ^a   Nakase, Hiroyuki ^a   Nonaka, Jun Ichi ^a   Ouji, Yukiteru ^a   Ishizaka, Shigeaki ^a   Sakaki, Toshisuke ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Allogeneic transplantation; ES cells; Immunosuppression; Parkinson's disease

Indexed keywords

APOMORPHINE; CYCLOSPORIN A; OXIDOPAMINE; PHOSPHATE BUFFERED SALINE; TYROSINE 3 MONOOXYGENASE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PARKINSON DISEASE; STEM CELL TRANSPLANTATION;

ANIMALS; APOMORPHINE; CORPUS STRIATUM; CYCLOSPORINE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSON DISEASE; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 65749102601     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164108X339378     Document Type: Article

References (37)

1. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999; 22: 123-144 (Pubitemid 29144883)
2. Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20: 415-455
3. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitter in Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement Disorder, Vol.2, London: Butterworths, 1987: pp. 166-230
4. Lindvall O, Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx 2004; 1: 382-393 (Pubitemid 46589366)
5. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-719 (Pubitemid 32204988)
6. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54: 403-414 (Pubitemid 37072046)
7. Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002; 5: 627-628 (Pubitemid 34742975)
8. Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28: 31-40
9. Lee SH, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000; 18: 675-679 (Pubitemid 30415305)
10. Zeng X, Cai J, Chen J, et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 2004; 22: 925-940
11. Yan Y, Yang D, Zarnowska ED, et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005; 23: 781-790 (Pubitemid 40791793)
12. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99: 2344-2349
13. Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002; 418: 50-56
14. Barberi T, Klivenyi P, Calingasan NY, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003; 21: 1200-1207
15. Takagi Y, Takahashi J, Saiki H, et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 2005; 115: 102-109
16. Kim DW, Chung S, Hwang M, et al. Stromal cell-derived inducing activity, nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells 2006; 24: 557-567
17. Nishimura F, Yoshikawa M, Kanda S,et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 2003; 21: 171-180
18. Rodriguez-Gomez JA, Lu JQ, Velasco I, et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 2007; 25: 918-928
19. Sanchez-Pernaute R, Studer L, Ferrari D, et al. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno1) after transplantation. Stem Cells 2005; 23: 914-922
20. Ben-Hur T, Idelson M, Khaner H, et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 2004; 22: 1246-1255
21. Park CH, Minn YK, Lee JY, et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 2005; 92: 1265-1276
22. Brederlau A, Correia AS, Anisimov SV, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006; 24: 1433-1440
23. Roy NS, Cleren C, Singh SK, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006; 12: 1259-1268
24. Lavoir MC, Weier J, Conaghan J, et al. Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reprod Biomed Online 2005; 11: 740-744
25. Wakayama S, Suetsugu R, Thuan NV, et al. Establishment of mouse embryonic stem cell lines from somatic cell nuclei by nuclear transfer into aged, fertilization-failure mouse oocytes. Curr Biol 2007; 17: R120-R121
26. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317 (Pubitemid 47080336)
27. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318-324
28. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 9864-9869
29. Magliocca JF, Held IK, Odorico JS. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 2006; 15: 707-717
30. Li L, Baroja ML, Majumdar A, et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22: 448-456
31. Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24: 221-229
32. Swijnenburg RJ, Tanaka M, Vogel H, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005; 112 (Suppl. I): S166-S172
33. Nussbaum J, Minami E, Laflamme MA, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J 2007; 21: 1345-1357
34. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24: 372-376 (Pubitemid 30187435)
35. Hooper M, Hardy K, Handyside A, et al. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 1987; 326: 292-295
36. Akasaki Y, Black KL, Yu JS. Dendritic cell-based immunotherapy for malignant gliomas. Expert Rev Neurother 2005; 5: 497-508 (Pubitemid 41021056)
37. Mrass P, Weninger W. Immune cell migration as a means to control immune privilege: Lessons from the CNS and tumors. Immunol Rev 2006; 213: 195-212